@ARTICLE{
author={Darba Josep|,Ascanio Meritxell|,Rodriguez Antonio|,Charman Sarah J|,Okwose Nduka Charles|,Stefanetti Renae J|,Groenewegen Amy|,Del Franco Annamaria|,Tafelmeier Maria|,Preveden Andrej T|0000-0003-3572-2604,Fuller Amy S|,Bano Fatima|,Sinclair David R|,Edwards Duncan|,Nelissen Anne P|,Malitas Petros N|,Zisaki Aikaterini|,Bosnic Zoran|,Vracar Petar|,Fornaro Alessandra|,Barlocco Fausto|,Fotiadis Dimitris|,Banerjee Prithwish|,MacGowan Guy A|,Fernandez Oscar|,Zamorano Jose Luis|,Jimenez-blanco Bravo Marta|,Maier Lars S|,Olivotto Iacopo|,Milli Massimo|,Rutten Frans H|,Mant Jonathan|,Velicki Lazar U|0000-0002-2907-819X,Seferovic Petar M|0000-0002-1955-4199,Filipovic Nenad D|0000-0001-9964-5615,Jakovljevic Djordje G|,STRATIFYHF investigators|},
year={2025},
title={Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness},
journal={ESC HEART FAILURE},
volume={},
number={},
pages={-},
document_type={Review; Early Access},
} 

@ARTICLE{
author={Charman Sarah J|,Okwose Nduka C|,Groenewegen A|,Tafelmeier M|,Banerjee P|,Fernandez Oscar G|,Zamorano JL|,Bravo M Jimenez Blanco|,Maier Lars S|,Olivotto I|,Rutten Frans H|,Mant Jonathan|,Velicki Lazar U|0000-0002-2907-819X,Seferovic Petar M|0000-0002-1955-4199,Jakovljevic Djordje G|},
year={2024},
title={Development and clinical validation of an artificial intelligence-based decision support system for predicting risk, diagnosis, and progression of heart failure (STRATIFYHF): a study protocol},
journal={EUROPEAN JOURNAL OF HEART FAILURE},
volume={26},
number={},
pages={166-166},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Velicki Lazar U|0000-0002-2907-819X,Popovic Dejana R|,Okwose Nduka Charles|,Preveden Andrej T|0000-0003-3572-2604,Tesic Milorad B|0000-0002-3758-3719,Tafelmeier Maria|,Charman Sarah J|,Macgowan Guy A|,Filipovic Nenad D|0000-0001-9964-5615,Ristic Arsen D|0000-0002-0713-1180,Olivotto Iacopo|,Maier Lars S|,Jakovljevic Djordje G|},
year={2023},
title={Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)},
journal={EUROPEAN HEART JOURNAL},
volume={44},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Velicki Lazar U|0000-0002-2907-819X,Preveden Andrej T|0000-0003-3572-2604,Tafelmeier Maria|,Olivotto Iacopo|,Barlocco Fausto|,Popovic Dejana R|,Maier Lars S|,Jakovljevic Djordje G|},
year={2020},
title={Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy},
journal={EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING},
volume={19},
number={1_SUPPL},
pages={S43-S44},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tafelmeier Maria|,Baessler Andrea|,Wagner Stefan|,Unsoeld Bernhard|,Preveden Andrej T|0000-0003-3572-2604,Barlocco Fausto|,Tomberli Alessia|,Popovic Dejana R|,Brennan Paul|,MacGowan Guy A|,Ristic Arsen D|0000-0002-0713-1180,Velicki Lazar U|0000-0002-2907-819X,Olivotto Iacopo|,Jakovljevic Djordje G|,Maier Lars S|},
year={2020},
title={Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy},
journal={CLINICAL CARDIOLOGY},
volume={43},
number={5},
pages={430-440},
document_type={Article},
}